Home

VAC091 Vaccine Started on April 12,2023

A Phase IIb randomised controlled trial of the safety, immunogenicity and efficacy of the blood-stage malaria vaccine candidates RH5.1 in Matrix-MTM and RH5.2-VLP in Matrix-MTM in infants aged 5-17 months in Burkina Faso.

Research

We are involved in the Health Research Venture

Clinical Research

We are at the forefront of drugs and vaccines trials in Africa

Data

We generate data to improve human health

Our Laboratories

Our global laboratories can provide diagnostics solutions for clinical trials across Africa and the world.

Learn More

Our Projects

CRUN performs study and teach in a variety of areas, including policy, epidemiology, behavioral science, diagnostics and pharmaceutical development, clinical trials, and bench science.